Direct healthcare costs of Rome IV or Rome III-defined irritable bowel syndrome in the United Kingdom.
Vivek C GoodooryCho Ee NgChristopher J BlackAlexander Charles FordPublished in: Alimentary pharmacology & therapeutics (2022)
We estimate annual direct healthcare costs of IBS of between £1.3 and £2 billion in the United Kingdom.